Mr. Dominic Gray reports

SERNOVA ANNOUNCES CHANGE OF LOCATION OF ANNUAL MEETING OF SHAREHOLDERS

Sernova Corp.'s board of directors has considered current COVID-19 public health restrictions and determined it to be in the best interests of the corporation and its shareholders to change the location of the corporation's annual meeting of shareholders (AGM) to the offices of Sernova at 700 Collip Circle, Suite 114, London, Ont., N6G 4X8. The AGM will be held on Friday, May 29, 2020, at 12 p.m. ET. Shareholders are reminded to submit their votes by proxy before the proxy deadline of 12 p.m. ET on Wednesday, May 27, 2020. Shareholders may choose to attend the meeting by teleconference but will not be able to vote via teleconference. All other matters of the AGM remain the same as published in the AGM proxy materials mailed to the shareholders and posted on SEDAR.

The conference call details for shareholders to call into the AGM are set out below.

United States toll-free:  1-877-366-0711

Canada toll-free:  1-866-627-1651

International toll-free:  1-302-709-8446

The conference participant passcode is 109 985 50.

Following the AGM, Sernova will hold a chief executive officer conference call at 1 p.m. ET for its shareholders and investors. The CEO conference call details are set out below.

Meeting:  on-line

Meeting ID:  960 3972 0141

Password:  Sernova

A recording will be available following the meeting at Sernova's website.

About Sernova Corp.

Sernova is developing regenerative medicine therapeutic technologies using a medical device and immune-protected therapeutic cells (human donor cells, corrected human cells and stem-cell-derived cells) to improve the treatment and quality of life of people with chronic metabolic diseases, such as insulin-dependent diabetes, blood disorders, including hemophilia, and other diseases treated through the replacement of proteins or hormones missing or in short supply within the body.